Purpose: Vascular endothelial dysfunction is well established in type 2 diabetes. Interleukin-12 (IL-12) and endoplasmic reticulum (ER) stress are up-regulated in type 2 diabetic patients and animal models of type 2 diabetes. However, the role and underlying mechanisms of IL-12 and the ER stress CHOP in endothelial dysfunction are not fully understood.Methods: We generated double knockout mice between db−/db− and p40IL-12−/− mice (db−/db−p40-IL−12-/-) and endoplasmic (ER) stress-CHOP−/− mice (db−/db−CHOP-/-). We performed a glucose tolerance test (GTT) to determine the effect of IL-12 and ER stress CHOP on glucose metabolism. We assessed the endothelial function and determined the phosphorylation level of eNOS, Akt, AMPK, and the expression of ER stress (CHOP, BIP), and oxidative stress (Nox2 and Nox4 and NADPH oxidase activity).Results: The results showed that GTT was improved in db-/db−p40-IL−12-/- and db−/db−CHOP-/- suggesting IL-12 and CHOP as parts of a mechanism involved in the development of type 2 diabetes. The microvascular endothelial dysfunction in db−/db− mouse is associated with decreased phosphorylated eNOS, Akt, AMPK, and increased CHOP, BIP, Nox2, and Nox4 expressions. Interestingly, disrupting IL-12 and ER stress CHOP in db−/db− mice significantly improved endothelial function, increased survival markers expression and decreased ER and oxidative stress.Conclusion: Using a genetic approach, these findings provide evidence that IL-12 and ER stress CHOP play a significant role in microvascular endothelial dysfunction in type 2 diabetes.
Research Date	
              Research Department	
              
          Research Journal	
              Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
          Research Member	
          
      Research Publisher	
              Dove Press
          Research Vol	
              15
          Research Year	
              2022
          Research_Pages	
              2633-2642
          Research Abstract	
               Do you have any questions?
Do you have any questions?  
           
            